儿童CLIF-SOFA评分是预测失代偿期慢性肝病患儿28天死亡率的最佳指标
该前瞻性研究纳入110例失代偿期慢性肝病(DCLD)患儿,评估Child-Pugh、PELD和pCLIF-SOFA评分对28天死亡率的预测价值。37例(33.6%)在28天内死亡,pCLIF-SOFA的曲线下面积(0.977)优于Child-Pugh(0.815)和PELD(0.741)。pCLIF-SOFA评分≥11分预测28天死亡率的敏感度和特异度分别为94.9%和91.5%。
要点
- pCLIF-SOFA评分预测28天死亡率优于Child-Pugh和PELD评分。
- pCLIF-SOFA评分≥11分预测28天死亡率的敏感度94.9%、特异度91.5%。
- 器官衰竭和低血清钠是多变量分析中的独立不良预后预测因素。
核心结论
- 34%的DCLD患儿短期预后不良,器官衰竭和低血清钠是独立预测因素。
- pCLIF-SOFA在预测28天死亡率方面优于Child-Pugh和PELD评分。
- 本研究支持使用基于器官衰竭的评分来预测DCLD患儿的预后。
研究设计与样本
- 前瞻性研究,纳入110例DCLD患儿(74例男孩,中位年龄96个月,范围4-204个月),随访28天确定结局。
- 入院时计算Child-Pugh、PELD和pCLIF-SOFA评分,进行单变量和多变量分析以确定最佳预测因素。
主要发现
- 37例(33.6%)在28天内死亡。
- 死亡显著危险因素包括:较高的国际标准化比值(HR 1.17;95%CI 1.04-1.31;p<0.001)、较高的胆红素(HR 1.04;95%CI 1.01-1.08;p<0.001)、较低的 albumin(HR 0.46;95%CI 0.27-0.77;p=0.03)、较低的钠(HR 0.93;95%CI 0.89-0.98;p=0.01)、无可治疗病因(HR 2.00;95%CI 1.40-2.87;p=0.001)和存在器官衰竭(HR 3.22;95%CI 1.98-10.58;p<0.001)。
- 多变量分析中,器官衰竭和血清钠是不良结局的独立预测因素。
- 非存活者的pCLIF-SOFA评分(16[9-22] vs. 9[5-15])、Child-Pugh评分(11[9-15] vs. 10[8-14])和PELD评分(22.2[7.5-45.3] vs. 15.3[4.5-23.9])均显著高于存活者。
- 曲线下面积:pCLIF-SOFA为0.977,Child-Pugh评分为0.815,PELD评分为0.741。
关键数值与推荐
- pCLIF-SOFA评分≥11分预测28天死亡率,敏感度94.9%,特异度91.5%。
- pCLIF-SOFA评分曲线下面积0.977,Child-Pugh评分0.815,PELD评分0.741。
临床怎么用
- 作者认为,本研究支持使用基于器官衰竭的评分来预测DCLD患儿的预后。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Early identification of children with decompensated chronic liver disease (DCLD) at risk of short-term mortality helps improve outcome. We aimed to evaluate the predictors of outcome and role of Child-Pugh, pediatric end-stage liver disease (PELD) and pediatric chronic liver failure sequential organ failure assessment (pCLIF-SOFA) score for prognosticating 28-day mortality in children with DCLD. METHODS: DCLD children were prospectively evaluated with a clinico-laboratory proforma and followed for 28 days to determine outcome. Child-Pugh, PELD and pCLIF-SOFA were calculated at admission. Univariate and multivariate analysis was performed to identify the best predictors of outcome. RESULTS: A total of 110 children (74 boys, 96 [4-204] months) were enrolled and 37 (33.6%) died at 28 days. Significant risk factors for mortality were a higher international normalized ratio (hazard ratio [HR] 1.17; 95% CI 1.04-1.31; p <0.001) and bilirubin (HR 1.04; 95% CI 1.01-1.08; p <0.001), lower albumin (HR 0.46; 95% CI 0.27-0.77; p = 0.03) and sodium (HR 0.93; 95% CI 0.89-0.98; p = 0.01), absence of treatable etiology (HR 2.00; 95% CI 1.40-2.87; p = 0.001) and presence of organ failure (HR 3.22; 95% CI 1.98-10.58; p <0.001). Organ failure and serum sodium were independent predictors of poor outcome on multivariate analysis. pCLIF-SOFA (16 [9-22] vs. 9 [5-15]), Child-Pugh (11 [9-15] vs. 10 [8-14]) and PELD (22.2 [7.5-45.3] vs. 15.3 [4.5-23.9]) scores were significantly higher in non-survivors. The area under the curve was 0.977 for pCLIF-SOFA, 0.815 for Child-Pugh score, and 0.741 for PELD score. A pCLIF-SOFA score of ≥11 identified 28-day mortality with a sensitivity and specificity of 94.9% and 91.5%, respectively. CONCLUSION: Thirty-four percent of children with DCLD have a poor short-term outcome. Organ failure and low serum sodium are independent predictors of outcome. pCLIF-SOFA performs better than Child-Pugh and PELD in prognostication of 28-day mortality. Our study supports the use of scores based on organ failure in prognosticating children with DCLD. LAY SUMMARY: The ability to predict the course of a disease is an important part of the assessment, enabling timely interventions that improve outcomes. We evaluated the outcome (death vs. survival) and compared three different scoring systems for their ability to predict mortality within 28 days in children with decompensated chronic liver disease (DCLD). One-third of children with DCLD died within 28 days and the pediatric chronic liver failure sequential organ failure assessment score, which considers the main organ systems of the body (lungs, liver, brain, kidney, blood and cardiac) fared better for identification of children with a poor outcome than the Child-Pugh and pediatric end-stage liver disease score which comprise of only liver-related parameters. Our study supports the use of scores based on organ failure in prognosticating children with DCLD.
引用
- Bolia R, Srivastava A, Yachha SK, et al. Pediatric CLIF-SOFA score is the best predictor of 28-day mortality in children with decompensated chronic liver disease. J Hepatol. 2017. PMID: 29024698. doi:10.1016/j.jhep.2017.10.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。